Showing posts with label treatments. Show all posts
Showing posts with label treatments. Show all posts

Saturday, September 29, 2018

What are the treatments for type 2 diabetes?

Type 2 diabetes treatment:
What are the treatments for type 2 diabetes?

1.Oral hypoglycemic agent

  •  biguanides (such as metformin) These drugs have the ability to reduce the liver's glucose output and help muscle cells, fat cells and liver absorb more glucose from the blood, thus lowering blood sugar levels.
  • Sulfonylureas (such as glimepiride, glibenclamide, gliclazide, and gliclazone) The main role of these oral hypoglycemic agents is to stimulate islets to release more insulin.
  • Thiazolidinediones (such as rosiglitazone and pioglitazone) These drugs can enhance insulin sensitivity and help muscle cells, fat cells and liver absorb more glucose in the blood. However, rosiglitazone may increase the risk of heart disease.
  • Benzoic acid derivatives (such as repaglinide and nateglinide) The mechanism of action of these drugs is similar to that of sulfonylureas, mainly to stimulate the pancreas to produce more insulin to lower blood sugar.
  • α-glucosidase inhibitors (such as acarbose and voglibose) These hypoglycemic agents can inhibit the absorption of sugar by the human digestive tract, the main role is to reduce postprandial blood glucose.


What are the treatments for diabetes?

There is currently no cure for diabetes, but diabetes can be controlled by a variety of treatments. It mainly includes five aspects: education for diabetic patients, self-monitoring blood sugar, diet therapy, exercise therapy and drug therapy.
What are the treatments for diabetes?

General treatment
1.Education
To educate people with diabetes to understand the basics of diabetes, to build confidence in the fight against disease, how to control diabetes, and to control the health benefits of diabetes. Develop appropriate treatment options based on the characteristics of each diabetic patient.

2.Self-monitoring blood sugar
With the gradual popularization of small and fast blood glucose meters, patients can adjust the dose of hypoglycemic drugs at any time according to blood sugar levels. Type 1 diabetes is monitored at least 4 times a day (pre-meal) when intensively treated, and 8 times before blood glucose is unstable (before, after, at night, before bedtime and at 3:00 am). Fasting blood glucose should be controlled below 7.2 mmol/L during intensive therapy, blood glucose less than 10 mmol/L two hours after meal, and HbA1c less than 7%. The frequency of self-monitoring blood glucose in patients with type 2 diabetes can be appropriately reduced.